Phase I Clinical Trial of Fibronectin CH296-Stimulated T Cell Therapy in Patients with Advanced Cancer

• Takeshi Ishikawa,

  Affiliations Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan, Department of Cancer ImmunoCell Regulation, Kyoto Prefectural University of Medicine, Kyoto, Japan

  ⨯
• Satoshi Kokura ,

  * E-mail: s-kokura@koto.kpu-m.ac.jp

  Affiliations Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan, Department of Cancer ImmunoCell Regulation, Kyoto Prefectural University of Medicine, Kyoto, Japan

  ⨯
• Tatsuji Enoki,

  Affiliation Center for Cell and Gene Therapy, Takara Bio Inc, Otsu, Japan

  ⨯
• Naoyuki Sakamoto,

  Affiliation Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

  ⨯
• Tetsuya Okayama,

  Affiliations Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan, Department of Cancer ImmunoCell Regulation, Kyoto Prefectural University of Medicine, Kyoto, Japan

  ⨯
• Mitsuko Ideno,

  Affiliation Center for Cell and Gene Therapy, Takara Bio Inc, Otsu, Japan

  ⨯
• Junichi Mineno,

  Affiliation Center for Cell and Gene Therapy, Takara Bio Inc, Otsu, Japan

  ⨯
• Kazuko Uno,

  Affiliation Division of Basic Research, Louis Pasteur Center for Medical Research, Kyoto, Japan

  ⨯
• Naohisa Yoshida,

  Affiliation Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

  ⨯
• Kazuhiro Kamada,

  Affiliation Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

  ⨯
• Kazuhiro Katada,

  Affiliation Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

  ⨯
• Kazuhiko Uchiyama,

  Affiliation Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

  ⨯
• Osamu Handa,

  Affiliation Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

  ⨯
• Tomohisa Takagi,

  Affiliation Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

  ⨯
• Hideyuki Konishi,

  Affiliation Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

  ⨯
• Nobuaki Yagi,

  Affiliation Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

  ⨯
• Yuji Naito,

  Affiliation Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

  ⨯
• Yoshito Itoh,

  Affiliation Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

  ⨯
•  [ ... ],
• Toshikazu Yoshikawa

  Affiliation Department of Cancer ImmunoCell Regulation, Kyoto Prefectural University of Medicine, Kyoto, Japan

  ⨯
• [ view all ]
• [ view less ]